← Open Payments lookup

GRAHAM FARNHAM: Open Payments

NPI 1659822278 · BEACON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,135 in 66 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $951 · 2025 $1,135

Food & beverage: $1,135
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$330
ABBVIE INC.19$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$216
Teva Pharmaceuticals USA, Inc.6$98
Supernus Pharmaceuticals, Inc.4$59
Takeda Pharmaceuticals U.S.A., Inc.3$50
E.R. Squibb & Sons, L.L.C.3$47
Lundbeck LLC1$18
Bausch Health US, LLC1$17

Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, UZEDY, Qelbree, TRINTELLIX, COBENFY.

Industry payments across NY — which companies pay providers there.